NCT03961451

Brief Summary

study to correlate this level of objective physical activity with the levels of fatigue and quality of life in cancer patient being treated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2016

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 19, 2018

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

May 21, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 23, 2019

Completed
Last Updated

May 23, 2019

Status Verified

May 1, 2019

Enrollment Period

1 year

First QC Date

May 21, 2019

Last Update Submit

May 22, 2019

Conditions

Keywords

pedometer

Outcome Measures

Primary Outcomes (4)

  • Life satisfaction

    Satisfaction With Life Scale (Blais et al, 1989, french-canadian validation, Revue Canadienne des Sciences du Comportement, 21(2), 210-223.)

    2 months

  • Positive and negative affects measurement

    Positive and Negative Affect Schedule (PANAS scales) (Caci et Baylé, 2007 First traduction in French, Congrès de l'Encéphale, Paris, 25-27 january 2007)

    2 months

  • Fatigue

    Multidimensional Inventory Fatigue : Gentile et al, 2003, Validation of the French multidimensional fatigue inventory (MFI 20), Eur J Cancer Care)

    2 months

  • Quality of Life

    European Organisation for Research and Treatment of Cancer Questionnaire Quality of Life version 30

    2 months

Study Arms (2)

Group With Recommendations (GAR)

Patients in the GAR group will receive several recommendations and will have access to an online tool to increase motivation to engage in physical activity.

Device: Podometer

Control Group (GC)

No recommendation given

Device: Podometer

Interventions

PodometerDEVICE

Patients will be equipped with pedometers for 8 weeks, all day and must complete the number of steps each day. They will have to complete online evaluation questionnaires regularly. The main objective is to correlate the level of physical activity with the level of fatigue, quality of life and well-being weekly during an anticancer treatment.

Control Group (GC)Group With Recommendations (GAR)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All cancer pathologies, all treatments. Provided that the patient is fit for walking.

You may qualify if:

  • Patients being treated, Medical Day Hospital / HAD

You may not qualify if:

  • Inability to walk declared by an site medical doctor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut Paoli Calmettes

Marseille, Bouches Du Rhone, 13009, France

Location

Related Publications (1)

  • Villaron C, Cury F, Eisinger F, Cappiello MA, Marqueste T. Telehealth applied to physical activity during cancer treatment: a feasibility, acceptability, and randomized pilot study. Support Care Cancer. 2018 Oct;26(10):3413-3421. doi: 10.1007/s00520-018-4191-4. Epub 2018 Apr 19.

MeSH Terms

Conditions

Neoplasms, Second Primary

Condition Hierarchy (Ancestors)

Neoplasms

Study Officials

  • Maria Cappiello, MD

    Institut Paoli-Calmettes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2019

First Posted

May 23, 2019

Study Start

January 1, 2016

Primary Completion

December 31, 2016

Study Completion

April 19, 2018

Last Updated

May 23, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations